Butyrylcholinesterase deficiency (Q86859): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
A deficiência de butirilcolinesterase (BChE) é um distúrbio metabólico caracterizado por apneia prolongada após o uso de certos anestésicos, incluindo os relaxantes musculares succinilcolina ou mivacúrio e outros anestésicos locais de éster. A duração da apnéia prolongada varia significativamente dependendo da extensão da deficiência enzimática. | |||
| description / en | description / en | ||
Butyrylcholinesterase (BChE) deficiency is a metabolic disorder characterised by prolonged apnoea after the use of certain anaesthetic drugs, including the muscle relaxants succinylcholine or mivacurium and other ester local anaesthetics. The duration of the prolonged apnoea varies significantly depending on the extent of the enzyme deficiency. | |||
Revision as of 12:25, 15 August 2026
Butyrylcholinesterase (BChE) deficiency is a metabolic disorder characterised by prolonged apnoea after the use of certain anaesthetic drugs, including the muscle relaxants succinylcholine or mivacurium and other ester local anaesthetics. The duration of the prolonged apnoea varies significantly depending on the extent of the enzyme deficiency.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_581237559 |
||
| English | Butyrylcholinesterase deficiency |
Butyrylcholinesterase (BChE) deficiency is a metabolic disorder characterised by prolonged apnoea after the use of certain anaesthetic drugs, including the muscle relaxants succinylcholine or mivacurium and other ester local anaesthetics. The duration of the prolonged apnoea varies significantly depending on the extent of the enzyme deficiency. |
